Eğitim Bilgileri
2015 - Devam Ediyor
2015 - Devam EdiyorLisans Yandal
Hacettepe Üniversitesi, Hacettepe Üniversitesi Tıp Fakültesi, İç Hastalıkları , Türkiye
Yabancı Diller
B1 Orta
B1 Ortaİngilizce
Araştırma Alanları
Tıp
Sağlık Bilimleri
Dahili Tıp Bilimleri
İç Hastalıkları
İmmünoloji ve Romatoloji
Akademik Faaliyetlere Dayalı Araştırma Alanları
Avesis Araştırma Alanları
WoS Araştırma Alanları
Scopus Araştırma Alanları
Akademik Ünvanlar / Görevler
2015 - Devam Ediyor
2015 - Devam EdiyorAraştırma Görevlisi
Hacettepe Üniversitesi, Tıp Fakültesi (İngilizce), Dahili Tıp Bilimleri Bölümü
Makaleler
2025
20251. Evaluation of serum total antioxidant level, nutritional status and Mediterranean diet adherence of adult women with rheumatoid arthritis: a case-control study
BEKAR C., ARMAĞAN B., SARI A., AYAZ A.
BRITISH JOURNAL OF NUTRITION
, sa.2, ss.239-245, 2025 (SCI-Expanded, Scopus)
2024
20242. The impact of histopathological criteria for definite vasculitis in giant cell arteritis: retrospective analysis of temporal artery biopsies
Uzun G. S., GÖKÖZ Ö., ÖĞÜT B., HEPER A., Guresci S., KARDAŞ R. C., et al.
RHEUMATOLOGY INTERNATIONAL
, cilt.44, ss.2547-2554, 2024 (SCI-Expanded, Scopus)
2024
20243. ALMOST TWO AND HALF PRECENTAGE OF RA PATIENTS HAD DIFFICULT TO TREAT (D2T): RESULTS FROM E.PULSE, THE NATIONWIDE HEALTH DATA
Ayan G., Karabulut E., Satis H., ERDEN A., Bilgin E., Armagan B., et al.
ANNALS OF THE RHEUMATIC DISEASES
, 2024 (SCI-Expanded, Scopus)
2024
20244. REMARKING THE OSTEOPOROSIS IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS (AAV): DATA FROM EASTERN MEDITERRANEAN (TRVAS)
Yildirim T. D., Erpek E., Ulusoy B. O., Unaldi E., Cagdas O. S., Kardas R. C., et al.
ANNALS OF THE RHEUMATIC DISEASES
, 2024 (SCI-Expanded, Scopus)
2024
20245. COMORBIDITIES IN 40.643 PSORIATIC ARTHRITIS PATIENTS ACCORDING TO GENDER: RESULTS FROM E.PULSE, THE NATIONWIDE HEALTH DATA
Kalyoncu U., Satis H., Ayan G., Bilgin E., ERDEN A., Armagan B., et al.
ANNALS OF THE RHEUMATIC DISEASES
, 2024 (SCI-Expanded, Scopus)
2024
20246. DEMOGRAPHIC CHARACTERISTICS, COMORBIDITIES AND TREATMENT CHOICES OF EARLY AND LATE ONSET RA PATIENTS: RESULTS FROM E.PULSE,THE NATIONWIDE HEALTH DATA
Kucuksahin O., Satis H., Karabulut E., Ayan G., ERDEN A., Bilgin E., et al.
ANNALS OF THE RHEUMATIC DISEASES
, 2024 (SCI-Expanded, Scopus)
2024
20247. OFF-LABEL USE OF BIOLOGICS AND SMALL MOLECULES IN SJÖGREN DISEASE: REAL-WORLD DATA FROM THE INTERNATIONAL SJÖGREN BIG DATA COHORT
Quartuccio L., Brito-Zeron P., Rischmueller M., Lee A. Y. S., Trevisani V. F. M., Pasoto S., et al.
ANNALS OF THE RHEUMATIC DISEASES
, 2024 (SCI-Expanded, Scopus)
2024
20248. Unveiling cancer risk in ANCA-associated vasculitis: result from the Turkish Vasculitis Study Group (TRVaS)
BİLGİN E., Demirci Yıldırım T., Özdemir Ulusoy B., Öğüt T. S., Karabacak M., Sadioğlu Çağdaş Ö., et al.
Internal and Emergency Medicine
, 2024 (SCI-Expanded, Scopus)
2023
20239. Influence of exposure to climate-related hazards in the phenotypic expression of primary Sjögren's syndrome
Flores-Chavez A., Brito-Zeron P., Ng W. -., Szanto A., Rasmussen A., Priori R., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.41, sa.12, ss.2437-2447, 2023 (SCI-Expanded, Scopus)
2023
202310. Exposure to air pollution as an environmental determinant of how Sjögren's disease is expressed at diagnosis
Brito-Zeron P., Flores-Chavez A., Ng W. -., Horvath I. F., Rasmussen A., Priori R., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.41, sa.12, ss.2448-2457, 2023 (SCI-Expanded, Scopus)
2023
202311. Does decision tree analysis predict oral ulcer activity-related factors in patients with Behçet's syndrome?
Çandereli Z. Ö., Arslan T., Özdamar Ö., Yay M., Karaçayli Ü., Şişman-Kitapçi N., et al.
Clinical and experimental rheumatology
, cilt.41, sa.10, ss.2078-2086, 2023 (SCI-Expanded, Scopus)
2023
202312. Long-Term Results of Immunogenicity of Booster Vaccination against SARS-CoV-2 (Hybrid COV-RAPEL TR Study) in Turkiye: A Double-Blind, Randomized, Controlled, Multicenter Phase 2 Clinical Study
Ates I., Batirel A., Aydin M., Karadag F. Y., Erden A., KÜÇÜKŞAHİN O., et al.
Vaccines
, cilt.11, sa.7, 2023 (SCI-Expanded, Scopus)
2023
202313. Mortality risk factors in primary Sjögren syndrome: a real-world, retrospective, cohort study
Brito-Zerón P., Flores-Chávez A., Horváth I. F., Rasmussen A., Li X., Olsson P., et al.
eClinicalMedicine
, cilt.61, 2023 (SCI-Expanded, Scopus)
2023
202314. Association between oxygen delivery and digital ulcers in systemic sclerosis
AKDOĞAN A., Sari A., Sener Y. Z., Oksul M., Armagan B., KILIÇ L., et al.
Microvascular Research
, cilt.145, 2023 (SCI-Expanded, Scopus)
2023
202315. Pulmonary hypertension in Behçet’s disease: echocardiographic screening and multidisciplinary approach
ARMAĞAN B., OKŞUL M., ŞENER Y. Z., SARI A., ERDEN A., YARDIMCI G. K., et al.
Turkish Journal of Medical Sciences
, cilt.53, sa.2, ss.563-571, 2023 (SCI-Expanded, Scopus, TRDizin)
2023
202316. The impact of antiphospholipid antibodies in Takayasu arteritis
Firat Şentürk E., ERDEN A., SARI A., ARMAĞAN B., KILIÇ L., KALYONCU U., et al.
Turkish Journal of Medical Sciences
, cilt.53, sa.1, ss.199-205, 2023 (SCI-Expanded, Scopus, TRDizin)
2023
202317. Drug retention rate and predictive factors of drug survival for secukinumab in radiographic axial spondyloarthritis
Armagan B., KILIÇ L., Farisogullari B., YARDIMCI G. K., Bilgin E., BÖLEK E. Ç., et al.
RHEUMATOLOGY INTERNATIONAL
, cilt.43, sa.1, ss.147-156, 2023 (SCI-Expanded, Scopus)
2022
202218. Characterization and outcomes of 414 patients with primary SS who developed haematological malignancies
Hernandez-Molina G., Kostov B., Brito-Zeron P., Vissink A., Mandl T., Hinrichs A. C., et al.
RHEUMATOLOGY
, cilt.62, ss.243-255, 2022 (SCI-Expanded, Scopus)
2022
202219. Quality of life, disease activity and preferences for administration routes in rheumatoid arthritis: a multicentre, prospective, observational study
DİRESKENELİ R. H., KARADAĞ Ö., ATEŞ A., TUFAN A., Inanc N., KOCA S. S., et al.
RHEUMATOLOGY ADVANCES IN PRACTICE
, cilt.6, sa.3, 2022 (ESCI, Scopus)
2022
202220. Antibodies to Both Ro52 and Ro60 for Identifying Sjogren's Syndrome Patients Best Suited for Clinical Trials of Disease-Modifying Therapies
ARMAĞAN B., Robinson S. A., Bazoberry A., Perin J., Grader-Beck T., Akpek E. K., et al.
ARTHRITIS CARE & RESEARCH
, cilt.74, sa.9, ss.1559-1565, 2022 (SCI-Expanded, Scopus)
2022
202221. IS IT TIME TO DISSECTING GIANT CELL ARTERITIS INTO SUBPHENOTYPES? A CLOSE LOOK TO DATA OF EASTERN MEDITERRANEAN VASCULITIS CENTRE
Uzun G. S., Gokoz O., Tahillioglu Y., Sadigh S. L., Tan A. A., Ardali S., et al.
ANNALS OF THE RHEUMATIC DISEASES
, cilt.81, ss.1422, 2022 (SCI-Expanded, Scopus)
2022
202222. Pleuroparenchymal fibroelastosis in systemic sclerosis-associated interstitial lung disease
SARI A., ÖNDER Ö., ARMAĞAN B., BÖLEK E. Ç., Farisogullari B., BİLGİN E., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.52, sa.1, ss.83-88, 2022 (SCI-Expanded, Scopus, TRDizin)
2021
202123. TRENDS IN THE CHOICE OF FIRST BIOLOGIC AND TARGETED SYNTHETIC DMARD IN RHEUMATOID ARTHRITIS PATIENTS: 20-YEARS JOURNEY OF HURBIO REAL-LIFE REGISTRY
Ertenli A. I., Kalyoncu U., Karadag O., Kilic L., Akdogan A., Dogan I., et al.
ANNALS OF THE RHEUMATIC DISEASES
, cilt.80, ss.1124, 2021 (SCI-Expanded, Scopus)
2021
202124. CHANGES IN THE PRESCRIPTION PATTERNS OF THE SECOND-LINE BIOLOGIC AND TARGETED SYNTHETIC DMARD IN RHEUMATOID ARTHRITIS PATIENTS: 20-YEARS JOURNEY OF HUR-BIO REAL-LIFE REGISTRY
Kiraz S., Kalyoncu U., Karadag O., Kilic L., Akdogan A., Dogan I., et al.
ANNALS OF THE RHEUMATIC DISEASES
, cilt.80, ss.1124-1125, 2021 (SCI-Expanded, Scopus)
2021
202125. PRESCRIPTION PATTERNS OF THE SECOND BIOLOGIC DMARD IN PSORIATIC ARTHRITIS THROUGH THE LAST DECADE: HURBIO-PsA REAL LIFE EXPERIENCE
Kalyoncu U., Karadag O., Kilic L., Akdogan A., Dogan I., Bilgen S. A., et al.
ANNALS OF THE RHEUMATIC DISEASES
, cilt.80, ss.1299, 2021 (SCI-Expanded, Scopus)
2021
202126. Evaluating skeletal muscle mass with ultrasound in patients with systemic sclerosis
SARI A., EŞME M., ŞENGÜL AYÇİÇEK G., ARMAĞAN B., KILIÇ L., ERTENLİ A. İ., et al.
NUTRITION
, cilt.84, 2021 (SCI-Expanded, Scopus)
2021
202127. Phenotypic characterization of Familial Mediterranean Fever patients harboring variants of uncertain significance
SARI A., BODAKÇİ E., ARMAĞAN B., SATIŞ H., Atas N., YAŞAR BİLGE N. Ş., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.51, sa.4, ss.1695-1701, 2021 (SCI-Expanded, Scopus, TRDizin)
2021
202128. How did the updated hemodynamic definitions affect the frequency of pulmonary hypertension in patients with systemic sclerosis?
SARI A., ŞENER Y. Z., ARMAĞAN B., KILIÇ L., KAYA E. B., HEKİMSOY V., et al.
ANATOLIAN JOURNAL OF CARDIOLOGY
, cilt.25, sa.1, ss.30-35, 2021 (SCI-Expanded, Scopus, TRDizin)
2021
202129. Appendectomy history is associated with severe disease and colchicine resistance in adult familial Mediterranean fever patients
BODAKÇİ E., YAŞAR BİLGE N. Ş., AtaS N., ARMAĞAN B., SATIŞ H., SARI A., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.51, sa.4, ss.1706-1711, 2021 (SCI-Expanded, Scopus, TRDizin)
2021
202130. Predictors of persistent inflammation in familial Mediterranean fever and association with damage
Babaoglu H., ARMAĞAN B., BODAKÇİ E., SATIŞ H., Atas N., SARI A., et al.
RHEUMATOLOGY
, cilt.60, sa.1, ss.333-339, 2021 (SCI-Expanded, Scopus)
2020
202031. Moderation analysis exploring associations between age and mucocutaneous activity in Behcet's syndrome: A multicenter study from Turkey
MUMCU G., Yay M., Karacayli U., Aksoy A., Tas M. N., ARMAĞAN B., et al.
JOURNAL OF DERMATOLOGY
, cilt.47, sa.12, ss.1403-1410, 2020 (SCI-Expanded, Scopus)
2020
202032. Epidemiological profile and north-south gradient driving baseline systemic involvement of primary Sjogren's syndrome
Brito-Zeron P., Acar-Denizli N., Ng W., Horvath I. F., Rasmussen A., Seror R., et al.
RHEUMATOLOGY
, cilt.59, sa.9, ss.2350-2359, 2020 (SCI-Expanded, Scopus)
2020
202033. Predictors of drug retention and treatment response in axial spondyloarthritis patients treated with certolizumab: real-life results from the HURBIO registry
Bilgin E., Farisogullari B., Armagan B., Sari A., Yardimci G. K., Bolek E. C., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.38, sa.4, ss.609-614, 2020 (SCI-Expanded, Scopus)
2020
202034. Predictive factors for work-day loss in Behcet's syndrome: A multi-center study
MUMCU G., Yay M., Aksoy A., Tas M. N., ARMAĞAN B., SARI A., et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES
, cilt.23, sa.2, ss.240-246, 2020 (SCI-Expanded, Scopus)
2020
202035. Geoepidemiology and clinical characteristics of neonatal lupus erythematosus: a systematic literature review of individual patients' data
ERDEN A., Fanouriakis A., KILIÇ L., SARI A., ARMAĞAN B., BİLGİN E., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.50, sa.2, ss.281-290, 2020 (SCI-Expanded, Scopus, TRDizin)
2020
202036. Systemic phenotype related to primary Sjogren's syndrome in 279 patients carrying isolated anti-La/SSB antibodies
Acar-Denizli N., Horvath I. -., Mandl T., Priori R., Vissink A., Hernandez-Molina G., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.38, sa.4, 2020 (SCI-Expanded, Scopus)
2020
202037. Familial Mediterranean fever is associated with a wide spectrum of inflammatory disorders: results from a large cohort study
Atas N., ARMAĞAN B., Bodakci E., Satis H., SARI A., Bilge N. S. Y., et al.
RHEUMATOLOGY INTERNATIONAL
, cilt.40, sa.1, ss.41-48, 2020 (SCI-Expanded, Scopus)
2020
202038. Anti-interleukin-6 (tocilizumab) therapy in Takayasu's arteritis: a real life experience
KILIÇ L., KARADAĞ Ö., Erden A., SARI A., ARMAĞAN B., YARDIMCI G. K., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.50, sa.1, ss.31-36, 2020 (SCI-Expanded, Scopus, TRDizin)
2020
202039. Colchicine intolerance in FMF patients and primary obstacles for optimal dosing
Satis H., ARMAĞAN B., Bodakci E., Atas N., SARI A., Yasar Bilge N. S., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.50, sa.5, ss.1337-1343, 2020 (SCI-Expanded, Scopus, TRDizin)
2020
202040. Autoimmune congenital heart block and primary Sjogren's syndrome: characterisation and outcomes of 49 cases
Brito-Zeron P., Pasoto S. G., Robles-Marhuenda A., Mandl T., Vissink A., Armagan B., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.38, sa.4, 2020 (SCI-Expanded, Scopus)
2020
202041. Familial Mediterranean fever-associated infertility and underlying factors
Atas N., ARMAĞAN B., Bodakci E., Satis H., SARI A., Bilge N. S. Y., et al.
CLINICAL RHEUMATOLOGY
, cilt.39, sa.1, ss.255-261, 2020 (SCI-Expanded, Scopus)
2019
201942. Target Organ Associations in Polyarteritis Nodosa (PAN): Results of a Worldwide Collaboration Study
KARADAĞ Ö., Furuta S., Hocevar A., Gazel U., Hinojosa-Azaola A., UĞURLU S., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.71, 2019 (SCI-Expanded, Scopus)
2019
201943. Retention Rates and Response of Anti-TNF Treatments in the Enteropathic Spondylitis: HUR-BIO Real Life Results
YARDIMCI G. K., Farisogullari B., SARI A., KILIÇ L., ARMAĞAN B., BİLGİN E., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.71, 2019 (SCI-Expanded, Scopus)
2019
201944. Temporal Relationship Between Enteropathic Spondylitis Symptoms/diagnosis and Inflammatory Bowel Diseases Diagnosis: HUR-BIO Real Life Results
Farisogullari B., YARDIMCI G. K., SARI A., ARMAĞAN B., BİLGİN E., BÖLEK E. Ç., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.71, 2019 (SCI-Expanded, Scopus)
2019
201945. Mortality Ratio and Risk Factors in CT Confirmed Rheumatoid Arthritis Related Lung Disease: UIP, Pleural Effusion and the Time of Diagnosis of Rheumatoid Arthritis - Lung Disease
EKİCİ M., SARI A., BAYTAR Y., BÖLEK E. Ç., ARMAĞAN B., BİLGİN E., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.71, 2019 (SCI-Expanded, Scopus)
2019
201946. Are There Phenotypic Overlaps Between Giant Cell Arteritis Subgroups?
ARMAĞAN B., YILDIRIM A., SARI A., Farisogullari B., BİLGİN E., KILIÇ L., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.71, 2019 (SCI-Expanded, Scopus)
2019
201947. Systemic Manifestations of Primary Sjogren Syndrome out of the ESSDAI Classification: Prevalence and Clinical Relevance in a Large International, Multi-ethnic Cohort of Patients
Retamozo S., Acar-Denizli N., Rasmussen A., Horvath I. F., Baldini C., Priori R., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.71, 2019 (SCI-Expanded, Scopus)
2019
201948. Periaortitis and Coronary Arteritis in IgG4-Related Disease: Eastern Mediterranean Experience
YARDIMCI G. K., SARI A., Erden A., BÖLEK E. Ç., Farisogullari B., KILIÇ L., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.71, 2019 (SCI-Expanded, Scopus)
2019
201949. Increased incidence of spondyloarthropathies in patients with Takayasu arteritis: a systematic clinical survey
Esen S. G., ARMAĞAN B., Atas N., UÇAR M., Varan O., ERDEN A., et al.
JOINT BONE SPINE
, cilt.86, sa.4, ss.497-501, 2019 (SCI-Expanded, Scopus)
2019
201950. Proposal for a simple algorithm to differentiate adult-onset Still's disease with other fever of unknown origin causes: a longitudinal prospective study
BİLGİN E., Hayran M., Erden A., Armagan B., Sari A., KILIÇ L., et al.
CLINICAL RHEUMATOLOGY
, cilt.38, sa.6, ss.1699-1706, 2019 (SCI-Expanded, Scopus)
2019
201951. Successful Treatment of Amyloid A-Type Amyloidosis Due to Behcet Disease With Tocilizumab
İLBAY A., ERDEN A., SARI A., ARMAĞAN B., AKTAŞ B. Y., BÖLEK E. Ç., et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
, cilt.25, sa.4, 2019 (SCI-Expanded, Scopus)
2019
201952. Adalimumab as treatment for venous thrombosis in Behcet's syndrome: comment on the article by Emmi et al
Farisogullari B., SARI A., AYAR Ş. N., KILIÇ L., ARMAĞAN B., KARADAĞ Ö.
ARTHRITIS & RHEUMATOLOGY
, cilt.71, sa.4, ss.657, 2019 (SCI-Expanded, Scopus)
2019
201953. Change in PsAID-12 scores in patients continuing or discontinuing anti-TNF treatments in psoriatic arthritis: results from the HUR-BIO biologic registry
KALYONCU U., KİRAZ S., APRAŞ BİLGEN Ş. Ş., KARADAĞ Ö., AKDOĞAN A., KILIÇ L., et al.
CLINICAL RHEUMATOLOGY
, cilt.38, sa.4, ss.1187-1192, 2019 (SCI-Expanded, Scopus)
2019
201954. Frequency of Behcet's disease among a group of visually impaired adults
UYAROĞLU O. A., ŞEYHOĞLU E., ERDEN A., Vahabov C., BABAOĞLU H., ARMAĞAN B., et al.
IRISH JOURNAL OF MEDICAL SCIENCE
, cilt.188, sa.1, ss.333-336, 2019 (SCI-Expanded, Scopus)
2019
201955. Capillaroscopic findings in Turkish Takayasu arteritis patients
AKDOĞAN A., ERDEN A., Firat Senturk E., KILIÇ L., SARI A., ARMAĞAN B., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.49, sa.5, ss.1303-1307, 2019 (SCI-Expanded, Scopus, TRDizin)
2019
201956. Oral ulcer activity assessment with the composite index according to different treatment modalities in Behcet's syndrome: a multicentre study
Mumcu G., Karacayli U., Yay M., Aksoy A., Tas M. N., Armagan B., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.37, sa.6, ss.98-104, 2019 (SCI-Expanded, Scopus)
2019
201957. Systemic manifestations of primary Sjogren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patients
Retamozo S., Acar-Denizli N., Rasmussen A., Horvath I. F., Baldini C., Priori R., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.37, sa.3, 2019 (SCI-Expanded, Scopus)
2019
201958. Polyarteritis nodosa: lessons from 25 years of experience
Sonmez H. E., Armagan B., Ayan G., Barut K., Batu E. D., Erden A., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.37, sa.2, 2019 (SCI-Expanded, Scopus)
2018
201859. Rituximab Therapy in Renal Amyloidosis Secondary to Rheumatoid Arthritis
KILIÇ L., ERDEN A., ŞENER Y. Z., ARMAĞAN B., SARI A., KALYONCU U., et al.
BIOMOLECULES
, cilt.8, sa.4, 2018 (SCI-Expanded, Scopus)
2018
201860. Is the PET/CT first choice for differential diagnosis of fever of FUO/IUO?
ARMAĞAN B., ERDEN A., BEYDAŞ Ö., SARI A., KILIÇ L., KALYONCU U.
ANNALS OF THE RHEUMATIC DISEASES
, cilt.77, sa.11, 2018 (SCI-Expanded, Scopus)
2018
201861. Comparing immunoglobulin A vasculitis (Henoch-Schonlein purpura) in children and adults: a single-centre study from Turkey
Batu E. D., Sari A., Erden A., Sonmez H. E., Armagan B., Kalyoncu U., et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
, cilt.47, sa.6, ss.481-486, 2018 (SCI-Expanded, Scopus)
2018
201862. Multi-Biologic Usage in Rheumatoid Arthritis Is Not Infrequent in the Routine Practice
SARI A., KILIÇ L., ARMAĞAN B., ERDEN A., Yardimci G., AKDOĞAN A., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.70, 2018 (SCI-Expanded, Scopus)
2018
201863. Familial Mediterranean Fever Associated Infertility and Underlying Factors with Fertility
Atas N., ARMAĞAN B., Bodakci E., KAŞİFOĞLU T., Satis H., SARI A., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.70, 2018 (SCI-Expanded, Scopus)
2018
201864. How Immunological Profile Drives Clinical Phenotype of Primary Sjogren's Syndrome at Diagnosis: Analysis of 10.500 Patients (Sjogren Big Data Project)
Retamozo S., Acar-Denizli N., Ng W., Zeher M., Rasmussen A., Mandl T., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.70, 2018 (SCI-Expanded, Scopus)
2018
201865. Treatment Choices and Response Rates of SAPHO Syndrome: Single Center Case Series
ERDEN A., EKİCİ M., SARI A., ARMAĞAN B., KILIÇ L., APRAŞ BİLGEN Ş. Ş., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.70, 2018 (SCI-Expanded, Scopus)
2018
201866. Clinical Features and Outcome of Patients with Polyarteritis Nodosa - a Global Collaborative Study
KARADAĞ Ö., Furuta S., Hocevar A., Gazel U., Gopaluni S., ARMAĞAN B., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.70, 2018 (SCI-Expanded, Scopus)
2018
201867. Familial Mediterranean Fever Related Damage Assessed By Auto-Inflammatory Disease Damage Index (ADDI) and Associated Factors with Damage
TUFAN A., ARMAĞAN B., Bodakci E., KAŞİFOĞLU T., Satis H., Atas N., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.70, 2018 (SCI-Expanded, Scopus)
2018
201868. Effectiveness of a Biopsychosocial Exercise Approach in Rheumatic Diseases
ÜNAL E., ARIN G., KARACA N. B., OFLAZ F. B., ÖZÇADIRCI A., ERDEN A., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.70, 2018 (SCI-Expanded, Scopus)
2018
201869. Evaluation of Vitamin B12 Deficiency and Associated Factors in Patients With Systemic Sclerosis
Kilic D. T., AKDOĞAN A., KILIÇ L., SARI A., ERDEN A., ARMAĞAN B., et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
, cilt.24, sa.5, ss.250-254, 2018 (SCI-Expanded, Scopus)
2018
201870. Pulmonary hypertension in Takayasu arteritis
SARI A., ŞENER Y. Z., Fira E., ARMAĞAN B., ERDEN A., OKŞUL M., et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES
, cilt.21, sa.8, ss.1634-1639, 2018 (SCI-Expanded, Scopus)
2018
201871. Some concerns and improvements from Turkey
ÇINAR O. E., ERDEN A., SARI A., ARMAĞAN B., KILIÇ L.
ANNALS OF THE RHEUMATIC DISEASES
, cilt.77, sa.6, 2018 (SCI-Expanded, Scopus)
2018
201872. Blood group 'A' may have a possible modifier effect on familial Mediterranean fever and blood group '0' may be associated with colchicine resistance
ERDEN A., BATU AKAL E. D., ARMAĞAN B., SÖNMEZ H. E., SARI A., DEMİR S., et al.
BIOMARKERS IN MEDICINE
, cilt.12, sa.6, ss.565-572, 2018 (SCI-Expanded, Scopus)
2018
201873. CLINICAL AND IMMUNOLOGICAL PRIMARY SJOGREN SYNDROME' DISEASE PATTERNS ARE DRIVEN BY GENDER AND AGE AT DIAGNOSIS
Retamozo S., Hernandez-Molina G., Valim V., Moca Trevisani V. F., Pasoto S. G., Acar-Denizli N., et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
, cilt.24, 2018 (SCI-Expanded, Scopus)
2018
201874. HOW ETHNICITY MODIFIES SYSTEMIC ACTIVITY OF PRIMARY SJOGREN SYNDROME: ANALYSIS OF BASELINE ESSDAI SCORES IN A MULTI-ETHNIC INTERNATIONAL COHORT
Retamozo S., Hernandez-Molina G., Valim V., Moca Trevisani V. F., Pasoto S. G., Acar-Denizli N., et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
, cilt.24, 2018 (SCI-Expanded, Scopus)
2018
201875. Aspergillus Pneumonia in a Patient With Adult-Onset Still Disease Successfully Treated With Anakinra
BİLGİN E., ERDEN A., KILIÇ L., SARI A., ARMAĞAN B., KALYONCU U., et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
, cilt.24, sa.3, ss.156-158, 2018 (SCI-Expanded, Scopus)
2018
201876. SYSTEMIC SJOGREN PRESENTING WITHOUT SICCA SYNDROME: CHARACTERIZATION OF 240 PATIENTS ACCORDING TO THE NEW 2017 ACR/EULAR CLASSIFICATION CRITERIA
Retamozo S., Hernandez-Molina G., Valim V., Moca Trevisani V. F., Pasoto S. G., Acar-Denizli N., et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
, cilt.24, 2018 (SCI-Expanded, Scopus)
2018
201877. HOW DIFFERENT SYSTEMIC ORGAN INVOLVEMENTS OVERLAP IN PATIENTS WITH PRIMARY SJOGREN SYNDROME: ANALYSIS USING A MATHEMATICAL MODEL
Retamozo S., Hernandez-Molina G., Valim V., Moca Trevisani V. F., Pasoto S. G., Acar-Denizli N., et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
, cilt.24, 2018 (SCI-Expanded, Scopus)
2018
201878. Starting of biological disease modifying antirheumatic drugs may be postponed in rheumatoid arthritis patients with multimorbidity: Single center real life results
ARMAĞAN B., SARI A., ERDEN A., KILIÇ L., ERDAT E. C., KILIÇKAP S., et al.
MEDICINE
, cilt.97, sa.13, 2018 (SCI-Expanded, Scopus)
2018
201879. Multiple liver masses mimicking metastatic liver disease in an elderly patient
KÖKLÜ H., ARMAĞAN B., KARADAĞ Ö., KARÇAALTINCABA M., ÖZGEN KIRATLI M. P., Gedikoglu G., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.29, sa.1, ss.119-122, 2018 (SCI-Expanded, Scopus, TRDizin)
2018
201880. Systemic Sjogren presenting without sicca syndrome: characterization of 240 patients according to the new 2017 ACR/EULAR Classification Criteria
Retamozo S., Acar-Denizli N., Zeher M., Sivils K., Mandl T., Seror R., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.36, sa.3, 2018 (SCI-Expanded, Scopus)
2018
201881. Pulmonary Hypertension in Behcet's Disease
Armagan B., Oksul M., Sener Y. Z., Sari A., Erden A., Yardimci G. K., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.36, sa.6, 2018 (SCI-Expanded, Scopus)
2018
201882. Clinical and immunological disease patterns of primary Sjogren syndrome driven by gender and age at diagnosis
Retamozo S., Kostov B., Zeher M., Sivils K., Mandl T., Seror R., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.36, sa.3, 2018 (SCI-Expanded, Scopus)
2018
201883. Which definition should be used to determine colchicine resistance among patients with familial Mediterranean fever?
Erden A., Batu E. D., Sari A., Sonmez H. E., Armagan B., Demir S., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.36, sa.6, 2018 (SCI-Expanded, Scopus)
2018
201884. Pazopanib-Induced Hepatotoxicity in an Experimental Rat Model
Cetin B., Yilmaz G. E., ARMAĞAN B., AFŞAR B., Demirci U., GÜLBAHAR Ö., et al.
CHEMOTHERAPY
, cilt.63, sa.1, ss.39-45, 2018 (SCI-Expanded, Scopus)
2018
201885. Increased psoriasis frequency in patients with familial Mediterranean fever
ERDEN A., BATU AKAL E. D., ŞEYHOĞLU E., SARI A., SÖNMEZ H. E., ARMAĞAN B., et al.
UPSALA JOURNAL OF MEDICAL SCIENCES
, cilt.123, sa.1, ss.57-61, 2018 (SCI-Expanded, Scopus)
2018
201886. How ethnicity modifies systemic activity of primary Sjogren syndrome: analysis of baseline ESSDAI scores in a multi-ethnic international cohort
Retamozo S., Kostov B., Zeher M., Sivils K., Mandl T., Seror R., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.36, sa.3, 2018 (SCI-Expanded, Scopus)
2018
201887. How immunological profile drives clinical phenotype of primary Sjogren's syndrome at diagnosis: analysis of 10,500 patients (Sjogren Big Data Project)
Brito-Zeron P., Acar-Denizli N., Ng W. F., Zeher M., Rasmussen A., Mandl T., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.36, sa.3, 2018 (SCI-Expanded, Scopus)
2018
201888. How the different systemic organ involvements are overlapped in patients with primary Sjogren syndrome: analysis using a mathematical model
Retamozo S., Kostov B., Zeher M., Sivils K., Mandl T., Seror R., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.36, sa.3, 2018 (SCI-Expanded, Scopus)
2017
201789. ANKİLOZAN SPONDİLİT HASTALARINDA HASTALIK AKTİVİTESİ VE FONKSİYONELLİK ARASINDAKİ İLİŞKİNİN İNCELENMESİ
ARIN G., KARACA N. B., OFLAZ F. B., SARI A., ARMAĞAN B., KALYONCU U., et al.
Journal of Exercise Therapy and Rehabilitation , cilt.4, sa.3, 2017 (Hakemli Dergi)
2017
201790. Rituximab Experience in Patients With Long-standing Systemic Sclerosis-Associated Interstitial Lung Disease: A Series of 14 Patients
SARI A., Guven D., ARMAĞAN B., ERDEN A., KALYONCU U., KARADAĞ Ö., et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
, cilt.23, sa.8, ss.411-415, 2017 (SCI-Expanded, Scopus)
2017
201791. Patients with Ankylosing Spondylitis Had Better Adalimumab Survival Than Patients with Non-Radiographic Axial Spondyloarthritis
SARI A., ARMAĞAN B., ERDEN A., KILIÇ L., KARADAĞ Ö., AKDOĞAN A., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.69, 2017 (SCI-Expanded, Scopus)
2017
201792. Requirement and Response Rates of Biologic Agents in Polyarteritis Nodosa (PAN)
Karadag O., ARMAĞAN B., ERDEN A., Gopaluni S., SARI A., KİRAZ S., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.69, 2017 (SCI-Expanded, Scopus)
2017
201793. Older Age and Male Gender Are Independent Predictors of Quantiferon Positivity Among Adult Rheumatic Patients in a Tertiary Care Center from a BCG Vaccinated Country: Hur-BIO Single Center Real Life Results
ŞEYHOĞLU E., UYAROĞLU O. A., ERDEN A., KILIÇ L., ARMAĞAN B., SARI A., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.69, 2017 (SCI-Expanded, Scopus)
2017
201794. Starting of Biological Dmards May be Postponed in RA Patients with Multimorbidity: Single Centre Real Life Results
ARMAĞAN B., SARI A., ERDEN A., KILIÇ L., ERDAT E. C., KARADAĞ Ö., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.69, 2017 (SCI-Expanded, Scopus)
2017
201795. Blood Group "a" Was Increased in FMF Patients and Blood Group "0" May be Associated with Colchicine Resistance
ERDEN A., BATU AKAL E. D., ARMAĞAN B., SÖNMEZ H. E., SARI A., DEMİR S., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.69, 2017 (SCI-Expanded, Scopus)
2017
201796. Active Disease Is Associated with Dependency in Inflammatory Arthritis
Durmaz H. O., SARI A., ARMAĞAN B., ERDEN A., KILIÇ L., Karadag O., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.69, 2017 (SCI-Expanded, Scopus)
2017
201797. Which Definition Should be Used to Determine Colchicine Resistance in Patients with Familial Mediterranean Fever?
ERDEN A., BATU AKAL E. D., SARI A., SÖNMEZ H. E., ARMAĞAN B., DEMİR S., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.69, 2017 (SCI-Expanded, Scopus)
2017
201798. Pregnancy Outcomes in Male Patients Using Anti-Tumor Necrosis Factor Alpha Patients with Inflammatory Arthritis; Hur-BIO Real Life Experiences
UYAROĞLU O. A., ŞEYHOĞLU E., ERDEN A., KILIÇ L., ARMAĞAN B., SARI A., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.69, 2017 (SCI-Expanded, Scopus)
2017
201799. A Retrospective Study Comparing the Phenotype and Outcomes of Patients with Polyarteritis Nodosa between UK and Turkish Cohorts
Karadag O., ERDEN A., BİLGİNER Y., Gopaluni S., SARI A., ARMAĞAN B., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.69, 2017 (SCI-Expanded, Scopus)
2017
2017100. Comparing polyarteritis nodosa in children and adults: a single center study
ERDEN A., BATU AKAL E. D., SÖNMEZ H. E., SARI A., ARMAĞAN B., ARICI Z. S., et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES
, cilt.20, sa.8, ss.1016-1022, 2017 (SCI-Expanded, Scopus)
2017
2017101. Retention Rate of Etanercept in Patients with Rheumatoid Arthritis Is Better Than That of Monoclonal Antibody
ERDEN A., KILIÇ L., KARADAĞ Ö., KİRAZ S., KILIÇKAP S., AKDOĞAN A., et al.
Acta Medica , cilt.48, sa.3, ss.11-17, 2017 (TRDizin)
2017
2017102. The clinical features and outcomes of Turkish patients with IgG4-related disease: a single-center experience
KARADAĞ Ö., Erden A., AYHAN E. A., BÖLEK E. Ç., KALYONCU U., ARMAĞAN B., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.47, sa.5, ss.1307-1314, 2017 (SCI-Expanded, Scopus, TRDizin)
2016
2016103. The Characteristic Features of the Patients with Deficiency of Adenosine Deaminase 2 (DADA2)
ERDEN A., BATU AKAL E. D., Taskiran E. Z., SÖNMEZ H. E., SARI A., ARMAĞAN B., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.68, 2016 (SCI-Expanded, Scopus)
2015
2015104. Obesity Is Related with Active State in Psoriatic Arthritis and Rheumatoid Arthritis but Not Ankylosing Spondylitis at Real Life Biological Cohort
KALYONCU U., KILIÇ L., ERDEN A., SARI A., ARMAĞAN B., KARADAĞ Ö., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.67, 2015 (SCI-Expanded, Scopus)
2015
2015105. Cytomegalovirus (CMV) Infections in Patients with Rheumatic Diseases: Experience of a Referral Center
ŞENER Y. Z., AKTAŞ B. Y., Erden A., KILIÇ L., Armagan B., İNKAYA A. Ç., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.67, 2015 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2023
20231. PERFORMANCE OF 2022 ACR/EULAR GPA, EGPA AND MPA CLASSIFICATION CRITERIA IN TURKISH VASCULITIS STUDY GROUP PROSPECTIVE COHORT (TRVAS)
Bolek E. C., AYAN G., BİLGİN E., Ediboglu E. D., Duran E., Kardas C., et al.
European Congress of Rheumatology (EULAR), Milan, İtalya, 31 Mayıs - 03 Haziran 2023, ss.1597-1598, (Özet Bildiri)
2020
20202. CONCOMITANT PSORIATIC ARTHRITIS AND INFLAMMATORY BOWEL DISEASE IN THE PSA BIOLOGICAL REGISTRY: HUR-BIO REAL LIFE RESULTS
Yardimci G. K., Farisogullari B., Armagan B., Bilgin E., Bolek E. C., Duran E., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1174-1175, (Özet Bildiri)
2020
20203. SECUKINUMAB IS FREQUENTLY PREFERRED IN MULTI ANTI-TNF RESISTANCE SPONDYLOARTHRITIS PATIENTS: HUR-BIO REAL LIFE RESULTS
Armagan B., Kilic L., Yardimci G. K., Bilgin E., Farisogullari B., Bolek E. C., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.419-420, (Özet Bildiri)
2020
20204. FACTORS RELATED TO RADIOGRAPHIC PROGRESSION IN PATIENTS WITH RHEUMATOID ARTHRITIS-RELATED INTERSTITIAL LUNG DISEASE
Kalyoncu U., Ekici M., Bilgin E., Sari A., Baytar Y., Bolek E. C., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1394, (Özet Bildiri)
2020
20205. CAN FECAL CALPROTECTIN PREDICT FUTURE DEVELOPMENT OF INFLAMMATORY BOWEL DISEASE IN AXIAL SPONDYLOARTHRITIS PATIENTS? - TREASURE REAL-LIFE DATA
Yardimci G. K., Icacan O. C., Kabadayi G., Farisogullari B., Armagan B., Bes C., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1142-1143, (Özet Bildiri)
2020
20206. COLCHICINE INTOLERANCE IN FMF PATIENTS AND PRIMARY OBSTACLES FOR OPTIMAL DOSING
Satis H., Armagan B., Bodakci E., Atas N., Sari A., Yapar D., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.848, (Özet Bildiri)
2020
20207. REAL-LIFE EXPERIENCE FOR SECUKINUMAB IN PSORIATIC ARTHRITIS FROM HURBIO-PSA DATABASE
Bolek E. C., Bilgin E., Yardimci G. K., Farisogullari B., Duran E., Armagan B., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1665-1666, (Özet Bildiri)
2019
20198. ANEURYSM IN BEHCET'S DISEASE: MANAGEMENT, PROGNOSIS AND MORTALITY
ARMAĞAN B., BÖLEK E. Ç., SARI A., YARDIMCI G. K., Farisogullari B., BİLGİN E., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.422, (Özet Bildiri)
2019
20199. ENTEROPATHIC ARTHRITIS PATIENTS UNDER BDMARD TREATMENTS HAD FREQUENTLY RADIOGRAPHIC SACROILIITIS: HUR-BIO REAL LIFE RESULTS
YARDIMCI G. K., Farisogullari B., SARI A., KILIÇ L., ARMAĞAN B., BİLGİN E., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.478, (Özet Bildiri)
2019
201910. LYMPHOMA ARISING AT THE TIME OF DIAGNOSIS OF PRIMARY SJOGREN SYNDROME: A HIGHLY-ACTIVE SYSTEMIC SUBSET OF THE DISEASE
Retamozo S., Acar-Denizli N., Wan Fai Ng W. F. N., Szanto A., Rasmussen A., Seror R., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.138, (Özet Bildiri)
2019
201911. IMMUNE-RELATED ADVERSE EVENTS INDUCED BY CANCER IMMUNOTHERAPIES. BIG DATA ANALYSIS OF 13,051 CASES (IMMUNOCANCER INTERNATIONAL REGISTRY)
Ramos-Casals M., Lambotte O., Kostine M., Calabrese L., Suarez-Almazor M., Bingham C., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.607-608, (Özet Bildiri)
2019
201912. HOW THE AGE AT DIAGNOSIS MODIFIES THE PHENOTYPE OF PRIMARY SJOGREN SYNDROME: ANALYSIS IN 11,420 PATIENTS (BIG DATA SJOGREN PROJECT)
Retamozo S., Acar-Denizli N., Ng W. F., Horvath I. F., Rasmussen A., Seror R., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.416-417, (Özet Bildiri)
2019
201913. COMPARISON OF SURVIVAL RATES AMONG SUBGROUPS OF PATIENTS EVALUATED FOR FEVER OF UNKNOWN ORIGIN
BİLGİN E., ARMAĞAN B., SARI A., BÖLEK E. Ç., Farisogullari B., YARDIMCI G. K., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.573, (Özet Bildiri)
2019
201914. PREVALENCE, UNDERLYING FACTORS AND DAMAGE ASSOCIATED WITH CHRONIC PERSISTENT INFLAMMATION IN PATIENTS WITH FMF
BABAOĞLU H., ARMAĞAN B., Bodakci E., KAŞİFOĞLU T., Satis H., Atas N., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.571-572, (Özet Bildiri)
2019
201915. PHENOTYPE OF BIOPSY-PROVEN PATIENTS WITH PRIMARY SJOGREN SYNDROME LACKING RO AUTOANTIBODIES: HIGH FREQUENCY OF DRYNESS SYMPTOMS WITH LOW SYSTEMIC ACTIVITY (BIG DATA SJOGREN PROJECT)
Retamozo S., Acar-Denizli N., Ng W. F., Horvath I. F., Rasmussen A., Seror R., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1736-1737, (Özet Bildiri)
2019
201916. ANTIBODIES TO BOTH RO52 AND RO60 DEFINE A SUBSET OF SJOGREN'S MOST SUITABLE FOR CLINICAL TRIALS OF AGENTS TARGETING LYMPHOPROLIFERATIONS
ARMAĞAN B., Robinson S., Bazoberry A., Grader-Beck T., Baer A.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1160, (Özet Bildiri)
2019
201917. APPLICATION OF AUTO-INFLAMMATORY DISEASE DAMAGE INDEX (ADDI) TO PATIENTS WITH FMF AND RELATED FACTORS WITH DAMAGE
BABAOĞLU H., ARMAĞAN B., Bodakci E., KAŞİFOĞLU T., Satis H., Atas N., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1005, (Özet Bildiri)
2019
201918. CLINICAL FEATURES OF ANEURYSMAL BEHCET DISEASE
ARMAĞAN B., BÖLEK E. Ç., SARI A., YARDIMCI G. K., Farisogullari B., BİLGİN E., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1182, (Özet Bildiri)
2019
201919. VALIDATION OF THE GIANT CELL ARTERITIS CLASSIFICATION CRITERIA IN TURKISH PATIENTS
ARMAĞAN B., YILDIRIM A., Onur M., Yardimci G., KILIÇ L., KALYONCU U., et al.
19th International Vasculitis and ANCA Workshop, Pennsylvania, Amerika Birleşik Devletleri, 7 - 10 Nisan 2019, cilt.58, (Özet Bildiri)
2019
201920. VALIDITY OF ACR/EULAR 2017 PROVISIONAL CLASSIFICATION CRITERIA FOR ANCA-ASSOCIATED VASCULITIS IN TURKISH PATIENTS AND COMPARISON WITH 1990 CRITERIA
Yardimci G., BİLGİN E., ARMAĞAN B., Farisogullari B., KILIÇ L., AKDOĞAN A., et al.
19th International Vasculitis and ANCA Workshop, Pennsylvania, Amerika Birleşik Devletleri, 7 - 10 Nisan 2019, cilt.58, ss.39, (Özet Bildiri)
2018
201821. Effectiveness of a Biopsychosocial Exercise Approach in Rheumatic Diseases
ÜNAL E., ARIN G., KARACA N. B., OFLAZ F. B., ÖZÇADIRCI A., ERDEN A., et al.
American College of Rheumatology, ACR Convergence-2018, Chicago, IL, Amerika Birleşik Devletleri, 19 - 24 Ekim 2018, (Tam Metin Bildiri)
2018
201822. BİLİŞSEL EGZERSİZ TERAPİ YAKLAŞIMI ÖLÇEĞİNİN ROMATOİD ARTRİT TANISI ALAN BİREYLERDE GEÇERLİĞİ, GÜVENİRLİĞİ VE DUYARLILIĞININ BELİRLENMESİ
OFLAZ F. B., KARACA N. B., ÖZÇADIRCI A., ARIN G., KARAKAYA KARABULUT J., ERDEN A., et al.
XIX. Ulusal Romatoloji Kongresi, Türkiye, 26 - 30 Eylül 2018, (Özet Bildiri)
2018
201823. Pulmonary manifestations of antiphospholipid syndrome: A retrospective analysis of 67 patients
SARINÇ ULAŞLI S., KÖKSAL D., KARCIOĞLU O., ARMAĞAN B., SARI A., BABAOĞLU E., et al.
28th International Congress of the European-Respiratory-Society (ERS), Paris, Fransa, 15 - 19 Eylül 2018, cilt.52, (Özet Bildiri)
2018
201824. FOUR YEARS OF DELAY IN THE DIAGNOSIS OF SAPHO SYNDROME: SINGLE TERTIARY CENTRE EXPERIENCE
Erden A., Ekici M., Armagan B., Sari A., Yardimci G. K., Kilic L., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1552, (Özet Bildiri)
2018
201825. IS RELAPSE RATE OF GIANT CELL ARTERITIS IN REAL-LIFE EXPERIENCE LOWER THAN IN THE CONTROLLED TRIALS? RESULTS OF A RETROSPECTIVE, MULTI-CENTRE COHORT STUDY
Alibaz-Oner F., Balci M. A., Pamuk O. N., Zengin O., Tasci M., Dogru A., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1118-1119, (Özet Bildiri)
2018
201826. RETENTION RATES OF CERTOLIZUMAB PEGOL IN ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS PATIENTS: HUR-BIO REAL LIFE RESULTS
Armagan B., Sari A., Erden A., Yardimci G. K., Kilic L., Kalyoncu U., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1001-1002, (Özet Bildiri)
2018
201827. ASSOCIATION BETWEEN TISSUE OXYGEN DELIVERY AND DIGITAL ULCERS IN SYSTEMIC SCLEROSIS
Sari A., Sener Y. Z., Oksul M., Armagan B., Erden A., Kilic L., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.743, (Özet Bildiri)
2018
201828. FREQUENCY OF PULMONARY HYPERTENSION IN BEHCET'S DISEASE
Armagan B., Oksul M., Sener Y. Z., Sari A., Erden A., Yardimci G. K., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1471, (Özet Bildiri)
2018
201829. POLYARTERITIS NODOSA: OVER 20 YEARS' CLINICAL EXPERIENCE
Sonmez H. E., Armagan B., Ayan G., BARUT K., Batu E. D., Erden A., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.775-776, (Özet Bildiri)
2018
201830. INFLUENCE OF EPIDEMIOLOGY AND ETHNICITY ON SYSTEMIC EXPRESSION OF PRIMARY SJOGREN SYNDROME IN 9974 PATIENTS
Retamozo S., Acar-Denizli N., Ng W. F., Zeher M., Rasmussen A., Seror R., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.110, (Özet Bildiri)
2018
201831. ANTI-INTERLEUKIN-6 (TOCILIZUMAB) EXPERIENCE IN TAKAYASU'S ARTERITIS PATIENTS
Kilic L., Karadag O., Erden A., Sari A., Armagan B., Firat E., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.437-438, (Özet Bildiri)
2018
201832. COMPARISON OF CUT-OFF VALUES FOR FERRITIN TO DISCRIMINATE ADULT ONSET STILL'S DISEASE FROM OTHER CAUSES OF FEVER OF UNKNOWN ORIGIN: RESULTS OF A PROSPECTIVE STUDY
Bilgin E., Erden A., Armagan B., Kilic L., Sari A., Yardimci G., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1675, (Özet Bildiri)
2018
201833. PSAID-12 CAN BE USED TO DETERMINE THE ANTI-TNF TREATMENT DECISION IN THE PSORIATIC ARTHRITIS REGISTRY
Kalvoncu U., Kiraz S., Bilgen S. A., Karadag O., Akdogan A., Kilic L., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1601-1602, (Özet Bildiri)
2018
201834. A NORTH-SOUTH WORLDWIDE GRADIENT IN SYSTEMIC ACTIVITY OF PRIMARY SJOGREN SYNDROME: INCREASED SEVERE DISEASE IN PATIENTS FROM SOUTHERN COUNTRIES
Retamozo S., Acar-Denizli N., Ng W. F., Zeher M., Rasmussen A., Seror R., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1190, (Özet Bildiri)
2018
201835. HOW TO DIFFERENTIATE ADULT ONSET STILL'S DISEASE FROM OVERALL OTHER CAUSES OF FEVER OF UNKNOWN ORIGIN: RESULTS OF A PROSPECTIVE STUDY FROM A TERTIARY REFERRAL CENTRE
BİLGİN E., Erden A., Armagan B., KILIÇ L., Sari A., YARDIMCI G. K., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1156-1157, (Özet Bildiri)
2018
201836. WHICH ONE IS MORE VALUABLE FOR DIAGNOSIS OF ADULT ONSET STILL'S DISEASE? SOLELY NEUTROPHILIA OR LEUKOCYTOSIS WITH NEUTROPHILIA?
Bilgin E., Erden A., Armagan B., Kilic L., Sari A., Yardimci G., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1150, (Özet Bildiri)
2018
201837. IDIOPATHIC GRANULOMATOUS MASTITIS MAY RESPONSE WELL TO COMBINATION OF IMMUNOSUPRESIVES AND GLUCOCORTICOIDS
Sari A., Konan A., Akpinar M., Armagan B., Erden A., Kilic L., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1152-1153, (Özet Bildiri)
2017
201738. ANKİLOZAN SPONDİLİT HASTALARINDA HASTALIK AKTİVİTESİ VE FONKSİYONELLİK ARASINDAKİ İLİŞKİNİN İNCELENMESİ
ARIN G., TÜRKMEN N. B., OFLAZ F. B., SARI A., ARMAĞAN B., KALYONCU U., et al.
3.Ulusal Romatolojik Rehabilitasyon Kongresi, Türkiye, 6 - 08 Ekim 2017, cilt.4, ss.22, (Özet Bildiri)
2017
201739. Starting of Biological Dmards May be Postponed in RA Patients with Multimorbidity: Single Centre Real Life Results
ARMAĞAN B., SARI A., ERDEN A., KILIÇ L., ERDAT E. C., KARADAĞ Ö., et al.
2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri)
2017
201740. Older Age and Male Gender Are Independent Predictors of Quantiferon Positivity Among Adult Rheumatic Patients in a Tertiary Care Center from a BCG Vaccinated Country: Hur-BIO Single Center Real Life Results
ŞEYHOĞLU E., UYAROĞLU O. A., ERDEN A., KILIÇ L., ARMAĞAN B., SARI A., et al.
2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri)
2017
201741. Patients with Ankylosing Spondylitis Had Better Adalimumab Survival Than Patients with Non-Radiographic Axial Spondyloarthritis
SARI A., ARMAĞAN B., ERDEN A., KILIÇ L., KARADAĞ Ö., AKDOĞAN A., et al.
2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri)
2017
201742. Which Definition Should be Used to Determine Colchicine Resistance in Patients with Familial Mediterranean Fever?
ERDEN A., BATU E. D., SARI A., SÖNMEZ H. E., ARMAĞAN B., FIRAT E., et al.
2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri)
2017
201743. Pregnancy Outcomes in Male Patients Using Anti-Tumor Necrosis Factor Alpha Patients with Inflammatory Arthritis Hur-BIO Real Life Experiences
UYAROĞLU O. A., ŞEYHOĞLU E., ERDEN A., KILIÇ L., ARMAĞAN B., SARI A., et al.
2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri)
2017
201744. A Retrospective Study Comparing the Phenotype and Outcomes of Patients with Polyarteritis Nodosa between UK and Turkish Cohorts
KARADAĞ Ö., ERDEN A., BİLGİNER Y., GOPALUNI S., SARI A., ARMAĞAN B., et al.
2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri)
2017
201745. Blood Group ”a” Was Increased in FMF Patients and Blood Group ”0” May be Associated with Colchicine Resistance
ERDEN A., BATU E. D., ARMAĞAN B., SÖNMEZ H. E., SARI A., DEMİR S., et al.
ARTHRITIS RHEUMATOLOGY, 19 - 24 Ekim 2017, (Tam Metin Bildiri)
2017
201746. PS 121- BAŞ BOYUN TÜMÖRÜNÜ TAKLİT EDEN WEGENER GRANÜLOMATOZ OLGUSU
DURMAZ H., ARMAĞAN B., SARI A., ERDEN A., AKDOĞAN A., ÖZTÜRK H.
19. Ulusal İç Hastalıkları Kongresi, Antalya, Türkiye, 11 - 15 Ekim 2017, (Özet Bildiri)
2017
201747. A Section of Rare Diseases in Hacettepe Adult Clinics in Rheumatology: Deficiency of Adenosine Deaminase 2 (DADA2)
BÖLEK E. Ç., ERDEN A., ÖZEN S., KARADAĞ Ö., KALYONCU U., BATU E. D., et al.
5th Rare Diseases Summer School, 7 - 09 Haziran 2017, (Tam Metin Bildiri)
2017
201748. EVALUATION OF VITAMIN B12 DEFICIENCY AND ASSOCIATED FACTORS IN PATIENTS WITH SYSTEMIC SCLEROSIS
Kilic D. T., Sari A., Armagan B., Erden A., Kilic L., Kilinckaya M., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.637-638, (Özet Bildiri)
2017
201749. ARE THE DEMOGRAPHIC AND CLINICAL FEATURES OF POLYARTERITIS NODOSA SIMILAR BETWEEN THE UK AND TURKEY?
Karadag O., Erden A., Batu E. D., Gopaluni S., Sari A., Armagan B., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.329, (Özet Bildiri)
2017
201750. ABATACEPT EXPERIENCE IN BIOLOGIC NAIVE RHEUMATOID ARTHRITIS PATIENTS: HUR-BIO REAL LIFE RESULTS
Sari A., Armagan B., Kilic L., Erden A., Karadag O., Akdogan A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.854-855, (Özet Bildiri)
2017
201751. THE USE OF RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: IN WHICH INFUSION INTERVALS WERE GIVEN AND HOW DID THEY RESPOND? HUR-BIO REAL LIFE RESULTS
Armagan B., Sari A., Erden A., Kilic L., Karadag O., Akdogan A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1194-1195, (Özet Bildiri)
2017
201752. FUNCTIONAL DISABILITY IN RA PATIENTS TREATED WITH BIOLOGICS: HUR-BIO REAL LIFE RESULTS
Sari A., Armagan B., Erden A., Kilic L., Karadag O., Akdogan A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1127, (Özet Bildiri)
2017
201753. . IGG4-RELATED DISEASE IN EASTERN MEDITERRANEAN: CLINICAL FEATURES AND OUTCOMES OF A LARGE COHORT
KARADAĞ Ö., ERDEN A., AYHAN E. A., BÖLEK E. Ç., ARMAĞAN B., KILIÇ L., et al.
EULAR 2017, 6 - 10 Haziran 2017, cilt.76, ss.720, (Özet Bildiri)
2017
201754. RAID COMPOSITE INDEX IN THE EVALUATION OF RA PATIENTS RECEIVING BIOLOGICAL TREATMENT: HUR-BIO REAL-LIFE RESULTS
Erden A., Kilic L., Armagan B., Sari A., Akdogan A., Bilgen S. A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1113, (Özet Bildiri)
2017
201755. QUANTIFERON (R)-TB GOLD IN-TUBE ASSAY CAN BE USED FOR LATENT TUBERCULOSIS SCREENING BEFORE BIOLOGICAL DRUG TREATMENT IN A BCG VACCINATED COUNTRY: HUR-BIO SINGLE CENTER REAL LIFE RESULTS
Seyhoglu E., Uyaroglu O. A., Erden A., Kilic L., Armagan B., Sari A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1412-1413, (Özet Bildiri)
2017
201756. THERE IS A COMMUNICATION PROBLEM BETWEEN PATIENT AND PHYSICIAN DURING PRE-CONCEPTIONAL PERIOD: HUR-BIO REAL LIFE RESULTS
Uyaroglu O. A., Seyhoglu E., Erden A., Kilic L., Armagan B., Sari A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.448, (Özet Bildiri)
2017
201757. RITUXIMAB EXPERIENCE IN PATIENTS WITH LONGSTANDING SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: A SERIES OF 14 PATIENTS
Sari A., Guven D., Armagan B., Kilic L., Erden A., Akdogan A.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1262-1263, (Özet Bildiri)
2017
201758. BIOLOGICAL THERAPY IN NON-SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS PATIENTS FOLLOWED IN ADULT RHEUMATOLOGY DEPARTMENT: HUR-BIO REAL LIFE RESULTS
Kilic L., Sari A., Armagan B., Erden A., Karadag O., Akdogan A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.402, (Özet Bildiri)
2017
201759. RESULTS OF SCREENING FOR VIRAL HEPATITIS IN RA PATIENTS TREATED WITH BIOLOGICS: HUR-BIO REAL LIFE RESULTS
Sari A., Armagan B., Erden A., Kilic L., Akdogan A., Bilgen S. A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1175, (Özet Bildiri)
2017
201760. ANKYLOSING SPONDYLITIS PATIENTS WITH UVEITIS HAD BETTER ADALIMUMAB RETENTION RATE: HUR-BIO REAL LIFE RESULTS
Armagan B., Sari A., Erden A., Kilic L., Guven D. C., Pashayev T., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1300-1301, (Özet Bildiri)
2017
201761. COMORBIDITY AND SURGERY HISTORY OF RHEUMATOID ARTHRITIS PATIENTS WHO ARE RECEIVING BIOLOGICAL AGENT
Armagan B., Sari A., Erden A., Kilic L., Erdat E. C., Karadag O., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.534, (Özet Bildiri)
2017
201762. WIDE HETEROGENEITY IN TREATMENT PROTOCOLS AND INAPPROPIATE USE OF PREDNISOLONE FOR ANTI-RO/LA ASSOCIATED-CONGENITAL HEART BLOCK: A SYSTEMATIC REVIEW OF 492 CASES
Erden A., Kilic L., Bilgin E., Fanouriakis A., Ceylan S., Hyrnabaccus B., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1215-1216, (Özet Bildiri)
2017
201763. PREMATURE CORONARY HEART DISEASE FREQUENCY IN RHEUMATOID ARTHRITIS WHO ARE RECEIVING BIOLOGIC AGENTS: HUR-BIO REAL LIFE RESULTS
Armagan B., Sari A., Erden A., Kilic L., Erdat E. C., Karadag O., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.250-251, (Özet Bildiri)
2017
201764. ADHERENCE OF RHEUMATIC PATIENTS TO INH PROPHYLAXIS PRESCRIBED BEFORE BIOLOGICAL TREATMENT: HUR-BIO SINGLE CENTER REAL LIFE RESULTS
Seyhoglu E., Uyaroglu O. A., Erden A., Kilic L., Armagan B., Sari A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1035, (Özet Bildiri)
2017
201765. PSORIASIS IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER
Erden A., Batu E. D., Bilgin E., Sonmez H. E., Seyhoglu E., Demir S., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.414, (Özet Bildiri)
2017
201766. THORAX CT FINDINGS IN A LARGE COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS: HUR-BIO REAL LIFE RESULTS
Sari A., Armagan B., Erden A., Kilic L., Karadag O., Akdogan A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.256, (Özet Bildiri)
2017
201767. Comorbidity and Surgery History of Rheumatoid Arthritis Patients Who Receiving Biological Agent
ARMAĞAN B., SARI A., ERDEN A., KILIÇ L., KARADAĞ Ö., AKDOĞAN A., et al.
MIRCIM 2017 TIHUD-TIP JOINT MEETING, Krakow, Polonya, 11 - 14 Mayıs 2017, (Özet Bildiri)
2017
201768. LEUKOCYTOCLASTIC VASCULITIS IN THE BONE MARROW
SARI A., ARMAĞAN B., ERDEN A., KILIÇ L., Ayhan A. S., KARADAĞ Ö.
18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.72, (Özet Bildiri)
2017
201769. SCALP NECROSIS IN NEUROFIBROMATOSIS TYPE-1 VASCULOPATHY: A DIAGNOSTIC DILEMMA
Guven D., SARI A., ARMAĞAN B., KİRAZ S., KILIÇ L., KARADAĞ Ö., et al.
18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.101-102, (Özet Bildiri)
2017
201770. EVALUATION OF ASSSOCIATION BETWEEN ANTIPHOSPHOLIPID ANTIBODIES OR LUPUS ANTICOAGULANT POSITIVITY AND SEVERITY OF VASCULAR INVOLVEMENT IN TAKAYASU ARTERITIS PATIENTS
FIRAT E., ERDEN A., SARI A., ARMAĞAN B., KILIÇ L., KALYONCU U., et al.
18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.48, (Özet Bildiri)
2017
201771. TWO-YEAR RESULTS OF A PROSPECTIVE VASCULITIS COHORT FROM EASTERN MEDITERRANEAN: DEMOGRAPHIC CHARACTERISTICS AND DISTRIBUTION OF THE VASCULITIDES FREQUENCIES
KARADAĞ Ö., APRAŞ BİLGEN Ş. Ş., ARMAĞAN B., SARI A., ERDEN A., BATU AKAL E. D., et al.
18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, (Özet Bildiri)
2017
201772. SUCCESSFUL TREATMENT OF AORTOENTERIC FISTULA A PATIENT WITH BEHCET DISEASE INTERFERON ALFA2A AND SURGERY
ARMAĞAN B., SARI A., ERDEN A., KILIÇ L., KALYONCU U., KARADAĞ Ö.
18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.94, (Özet Bildiri)
2016
201673. RITUXIMAB SEEMS OUTSTANDING BIOLOGICAL OPTION IN LATE ONSET RHEUMATOID ARTHRITIS: HUR-BIO REAL LIFE RESULTS
Kilic L., Erden A., Sari A., Armagan B., Karadag O., Akdogan A., et al.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.1022-1023, (Özet Bildiri)
2016
201674. DEMOGRAPHIC CHARACTERISTICS AND DISTRIBUTION OF THE VASCULITIDES FREQUENCIES: A REAL-LIFE EXPERIENCE OF VASCULITIS CENTER FROM EASTERN MEDITERRANEAN
Karadag O., Erden A., Bilgin E., Batu E. D., Armagan B., Sari A., et al.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.1096-1097, (Özet Bildiri)
2016
201675. COMMON AND UNCOMMON MANIFESTATIONS OF GRANULOMATOSIS WITH POLIANGIITIS (GPA) AT CHEST CT: A VASCULITIS CENTER EXPERIENCE
Taydas O., Kilic L., Atceken Z., Erden A., Armagan B., Sari A., et al.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.796, (Özet Bildiri)
2016
201676. DAPSA WITH TWENTY-EIGHT JOINT COUNTS MAY BE USEFUL FOR THE ASSESSMENT OF PSORIATIC ARTHRITIS
Kalyoncu U., Erden A., Kilic L., Sari A., Armagan B., Karadag O., et al.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.1159-1160, (Özet Bildiri)
2016
201677. DEMOGRAPHIC, CLINIC AND LABORATORY FEATURES OF 755 PATIENTS WITH NEONATAL LUPUS ERYTHEMATOSUS: SYSTEMATIC REVIEW
Erden A., Kilic L., Bilgin E., Ceylan S., Hymabaccus B., Sener Y. Z., et al.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.874, (Özet Bildiri)
2016
201678. COMPARING THE CHARACTERISTICS OF ADULT AND PEDIATRIC PATIENTS WITH POLYARTERITIS NODOSA
Erden A., Batu E. D., Bilgin E., Sonmez H. E., Armagan B., Sari A., et al.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.799, (Özet Bildiri)
Kitaplar
2017
20171. PATOFİZYOLOJİNİN TEMELLERİ
DURUSU TANRIÖVER M., SARI A., EŞME M., KOÇ YILDIRIM S., YILDIRIM M. Ş., BÖLEK E. Ç., et al.
PALME YAYINCILIK, 2017
Desteklenen Projeler
2017 - 2022
2017 - 2022